rescula Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rescula, and when can generic versions of Rescula launch?
Rescula is a drug marketed by Sucampo Pharma Llc and is included in one NDA.
The generic ingredient in RESCULA is unoprostone isopropyl. There are four drug master file entries for this compound. Additional details are available on the unoprostone isopropyl profile page.
Summary for rescula
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 34 |
Patent Applications: | 1,248 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for rescula |
DailyMed Link: | rescula at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for rescula
Paragraph IV (Patent) Challenges for RESCULA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
RESCULA | Ophthalmic Solution | unoprostone isopropyl | 0.15% | 021214 | 1 | 2014-05-12 |
US Patents and Regulatory Information for rescula
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sucampo Pharma Llc | RESCULA | unoprostone isopropyl | SOLUTION/DROPS;OPHTHALMIC | 021214-001 | Aug 3, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for rescula
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sucampo Pharma Llc | RESCULA | unoprostone isopropyl | SOLUTION/DROPS;OPHTHALMIC | 021214-001 | Aug 3, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Sucampo Pharma Llc | RESCULA | unoprostone isopropyl | SOLUTION/DROPS;OPHTHALMIC | 021214-001 | Aug 3, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Sucampo Pharma Llc | RESCULA | unoprostone isopropyl | SOLUTION/DROPS;OPHTHALMIC | 021214-001 | Aug 3, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for rescula
See the table below for patents covering rescula around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H0680571 | INTRAOCULAR TENSION DEPRESSANT | ⤷ Try a Trial |
Germany | 68928551 | ⤷ Try a Trial | |
Spain | 2052735 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for rescula
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0289349 | SPC/GB04/007 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ISOPROPYL(+)-(Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-(3-OXODECYL)CYCLOPENTYL)-5-HEPTENOATE; REGISTERED: CH 55634 01 20010329; UK PL00101/0667 20031112 |
0289349 | C300135 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: UNOPROSTONEZUUR, DESGEWENST IN DE VORM VAN EEN ESTER OF EEN ZOUT; NATL REGISTRATION NO/DATE: RVG 28628 20030708; FIRST REGISTRATION: FR 359 911-5 AND 359 912-1 20020917 |
0289349 | 300135 | Netherlands | ⤷ Try a Trial | 300135, 20080429, EXPIRES: 20130428 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |